AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 105 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 1,887,535 | $37,128,000 | 4.83% |
| FT Options LLC | 190,400 | $1,451,000 | 2.19% |
| DAFNA Capital Management LLC | 135,738 | $2,670,000 | 1.66% |
| Nantahala Capital Management | 1,367,947 | $26,908,000 | 1.32% |
| Perceptive Advisors | 3,260,000 | $64,124,000 | 1.22% |
| EAM Investors, LLC | 235,470 | $4,632,000 | 0.62% |
| 361 CAPITAL LLC | 139,489 | $2,744,000 | 0.53% |
| Opus Point Partners Management, LLC | 21,009 | $413,000 | 0.37% |
| EAGLE ASSET MANAGEMENT INC | 3,043,867 | $59,629,000 | 0.34% |
| Piermont Capital Management Inc. | 27,770 | $546,000 | 0.18% |